159 related articles for article (PubMed ID: 38692814)
1. Applications of Artificial Intelligence in Lung Pathology.
Hartman DJ
Surg Pathol Clin; 2024 Jun; 17(2):321-328. PubMed ID: 38692814
[TBL] [Abstract][Full Text] [Related]
2. A Review of Artificial Intelligence in Precise Assessment of Programmed Cell Death-ligand 1 and Tumor-infiltrating Lymphocytes in Non-Small Cell Lung Cancer.
Wu J; Lin D
Adv Anat Pathol; 2021 Nov; 28(6):439-445. PubMed ID: 34623343
[TBL] [Abstract][Full Text] [Related]
3. Role of artificial intelligence in the care of patients with nonsmall cell lung cancer.
Rabbani M; Kanevsky J; Kafi K; Chandelier F; Giles FJ
Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29405289
[TBL] [Abstract][Full Text] [Related]
4. Dual-scale categorization based deep learning to evaluate programmed cell death ligand 1 expression in non-small cell lung cancer.
Wang X; Chen P; Ding G; Xing Y; Tang R; Peng C; Ye Y; Fu Q
Medicine (Baltimore); 2021 May; 100(20):e25994. PubMed ID: 34011092
[TBL] [Abstract][Full Text] [Related]
5. Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell Lung Cancer.
Rigamonti A; Viatore M; Polidori R; Rahal D; Erreni M; Fumagalli MR; Zanini D; Doni A; Putignano AR; Bossi P; Voulaz E; Alloisio M; Rossi S; Zucali PA; Santoro A; Balzano V; Nisticò P; Feuerhake F; Mantovani A; Locati M; Marchesi F
Cancer Res; 2024 Apr; 84(7):1165-1177. PubMed ID: 38315789
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence-powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non-small cell lung cancer with better prediction of immunotherapy response.
Choi S; Cho SI; Ma M; Park S; Pereira S; Aum BJ; Shin S; Paeng K; Yoo D; Jung W; Ock CY; Lee SH; Choi YL; Chung JH; Mok TS; Kim H; Kim S
Eur J Cancer; 2022 Jul; 170():17-26. PubMed ID: 35576849
[TBL] [Abstract][Full Text] [Related]
7. Machine Learning and Artificial Intelligence-driven Spatial Analysis of the Tumor Immune Microenvironment in Pathology Slides.
Xu H; Cong F; Hwang TH
Eur Urol Focus; 2021 Jul; 7(4):706-709. PubMed ID: 34353733
[TBL] [Abstract][Full Text] [Related]
8. Using Artificial Intelligence to Identify Tumor Microenvironment Heterogeneity in Non-Small Cell Lung Cancers.
DuCote TJ; Naughton KJ; Skaggs EM; Bocklage TJ; Allison DB; Brainson CF
Lab Invest; 2023 Aug; 103(8):100176. PubMed ID: 37182840
[TBL] [Abstract][Full Text] [Related]
9. Utility of Machine Learning to Detect Cytomegalovirus in Digital Hematoxylin and Eosin-Stained Slides.
Post CS; Cheng J; Pantanowitz L; Westerhoff M
Lab Invest; 2023 Oct; 103(10):100225. PubMed ID: 37527779
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence as the next step towards precision pathology.
Acs B; Rantalainen M; Hartman J
J Intern Med; 2020 Jul; 288(1):62-81. PubMed ID: 32128929
[TBL] [Abstract][Full Text] [Related]
11. Artificial Intelligence-Aided Diagnosis of Breast Cancer Lymph Node Metastasis on Histologic Slides in a Digital Workflow.
Challa B; Tahir M; Hu Y; Kellough D; Lujan G; Sun S; Parwani AV; Li Z
Mod Pathol; 2023 Aug; 36(8):100216. PubMed ID: 37178923
[TBL] [Abstract][Full Text] [Related]
12. Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.
Grilley-Olson JE; Hayes DN; Moore DT; Leslie KO; Wilkerson MD; Qaqish BF; Hayward MC; Cabanski CR; Yin X; Socinski MA; Stinchcombe TE; Thorne LB; Allen TC; Banks PM; Beasley MB; Borczuk AC; Cagle PT; Christensen R; Colby TV; Deblois GG; Elmberger G; Graziano P; Hart CF; Jones KD; Maia DM; Miller CR; Nance KV; Travis WD; Funkhouser WK
Arch Pathol Lab Med; 2013 Jan; 137(1):32-40. PubMed ID: 22583114
[TBL] [Abstract][Full Text] [Related]
13. The artificial intelligence and machine learning in lung cancer immunotherapy.
Gao Q; Yang L; Lu M; Jin R; Ye H; Ma T
J Hematol Oncol; 2023 May; 16(1):55. PubMed ID: 37226190
[TBL] [Abstract][Full Text] [Related]
14. Assessment of tumour viability in human lung cancer xenografts with texture-based image analysis.
Turkki R; Linder N; Holopainen T; Wang Y; Grote A; Lundin M; Alitalo K; Lundin J
J Clin Pathol; 2015 Aug; 68(8):614-21. PubMed ID: 26021331
[TBL] [Abstract][Full Text] [Related]
15. The EU-funded I
Prelaj A; Ganzinelli M; Trovo' F; Roisman LC; Pedrocchi ALG; Kosta S; Restelli M; Ambrosini E; Broggini M; Pravettoni G; Monzani D; Nuara A; Amat R; Spathas N; Willis M; Pearson A; Dolezal J; Mazzeo L; Sangaletti S; Correa AM; Aguaron A; Watermann I; Popa C; Raimondi G; Triulzi T; Steurer S; Lo Russo G; Linardou H; Peled N; Felip E; Reck M; Garassino MC
Clin Lung Cancer; 2023 Jun; 24(4):381-387. PubMed ID: 36959048
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images.
Sadhwani A; Chang HW; Behrooz A; Brown T; Auvigne-Flament I; Patel H; Findlater R; Velez V; Tan F; Tekiela K; Wulczyn E; Yi ES; Mermel CH; Hanks D; Chen PC; Kulig K; Batenchuk C; Steiner DF; Cimermancic P
Sci Rep; 2021 Aug; 11(1):16605. PubMed ID: 34400666
[TBL] [Abstract][Full Text] [Related]
17. Deep Learning and Colon Cancer Interpretation: Rise of the Machine.
McHugh K; Pai RK
Surg Pathol Clin; 2023 Dec; 16(4):651-658. PubMed ID: 37863557
[TBL] [Abstract][Full Text] [Related]
18. Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab.
Baxi V; Lee G; Duan C; Pandya D; Cohen DN; Edwards R; Chang H; Li J; Elliott H; Pokkalla H; Glass B; Agrawal N; Lahiri A; Wang D; Khosla A; Wapinski I; Beck A; Montalto M
Mod Pathol; 2022 Nov; 35(11):1529-1539. PubMed ID: 35840720
[TBL] [Abstract][Full Text] [Related]
19. How to Validate Predictive Immunohistochemistry Testing in Pathology? A Practical Approach Exploiting the Heterogeneity of Programmed Death Ligand-1 Present in Non-Small Cell Lung Cancer.
Thunnissen E
Arch Pathol Lab Med; 2019 Jan; 143(1):11-12. PubMed ID: 30307747
[No Abstract] [Full Text] [Related]
20. Direct identification of ALK and ROS1 fusions in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning algorithms.
Mayer C; Ofek E; Fridrich DE; Molchanov Y; Yacobi R; Gazy I; Hayun I; Zalach J; Paz-Yaacov N; Barshack I
Mod Pathol; 2022 Dec; 35(12):1882-1887. PubMed ID: 36057739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
